FUJIFILM Biotechnologies operates as one of the life sciences industry’s most expansive contract development and manufacturing organizations (CDMOs), handling the translation of complex biologics, viral vectors, and advanced therapies from clinical development to commercial scale. Managing that transition requires rigid orchestration across supply chains, regulatory frameworks, and manufacturing floors. To support this operational execution, Travis Psencik, PMP, has joined the organization as a Program Manager.
About Travis Psencik
In the biopharmaceutical ecosystem, a manufacturing facility is only as effective as the schedule it runs on. A Program Manager at a global CDMO acts as the central node between a client’s scientific milestones and the manufacturer’s production realities. Bringing a certified Project Management Professional (PMP) into this role signals a focus on structured, risk-mitigated execution. Psencik steps into a position where he will be tasked with ensuring that complex manufacturing programs stay aligned with both internal capacity constraints and external client expectations.
While the specific therapeutic areas of his prior stops were not detailed in his initial announcement, holding a PMP certification in the life sciences sector indicates a formalized background in managing cross-functional teams, mitigating risk, and controlling project scope. The life sciences manufacturing environment is uniquely unforgiving when it comes to timeline deviations. A delayed tech transfer or a misaligned supply chain can push a batch schedule off by months, costing millions and delaying patient access to therapies. Certified project leadership is a critical asset for an organization operating at the scale of FUJIFILM Biotechnologies.
In the contract manufacturing space, program managers do not just track timelines; they navigate the friction points between tech transfer, quality assurance, and commercial delivery.
The demand for advanced biomanufacturing has surged over the past decade, and with it, the complexity of the programs being transferred into CDMO facilities. Whether managing the lifecycle of a monoclonal antibody or coordinating the multi-stage production of a novel biologic, program managers like Psencik are responsible for translating scientific intent into operational reality. They must balance the demands of the laboratory with the realities of the manufacturing floor, ensuring that every batch meets rigorous compliance standards while hitting delivery targets.
About FUJIFILM Biotechnologies
FUJIFILM Biotechnologies is a global contract development and manufacturing organization (CDMO) with extensive experience in the development and manufacture of recombinant proteins, vaccines, monoclonal antibodies, viral products, and medical countermeasures. The organization operates across a wide array of microbial, mammalian, and host/virus systems, providing the infrastructure necessary to scale biological therapies.
The company offers a comprehensive list of services, moving from cell line development through process and analytical development, all the way to clinical and commercial manufacturing. By operating massive, highly regulated facilities across multiple global hubs, the organization provides the critical capacity required by biopharmaceutical companies to advance their clinical pipelines. In an ecosystem where manufacturing bottlenecks frequently dictate the pace of clinical progress, CDMOs of this scale serve as the industrial backbone for the life sciences sector.
